Skip to main content
. 2021 Nov 11;12:773241. doi: 10.3389/fphar.2021.773241

TABLE 4.

Comparisons of the number of re-exacerbations and the cumulative months of the antibiotic usage within 12 months.

Drug group (n = 181) Control group (n = 186) P-value
No. of re-exacerbation 0.66 ± 0.91 0.92 ± 1.00 0.005
Months of oral antibiotics 1.29 ± 2.09 1.90 ± 2.33 0.001
Months of intravenous antibiotics 0.43 ± 0.79 0.65 ± 0.91 0.012

Data are presented as mean ± SD except as otherwise noted. No., number.